The Efficacy of Azelastine in the Prophylaxis of Acute Upper Respiratory Tract Infections-Reference-Cited by-同舟云学术

The Efficacy of Azelastine in the Prophylaxis of Acute Upper Respiratory Tract Infections

Published:2003-12 Issue:4 Volume:16 Page:275-282
ISSN:0883-1874
Container-title:Pediatric Asthma, Allergy & Immunology
language:en
Short-container-title:Pediatric Asthma, Allergy & Immunology

Author:

Simon Michael W.

Publisher

Mary Ann Liebert Inc

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology, and Child Health,Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology, and Child Health

Reference37 articles.

1. Review: Rhinoviruses and Their ICAM Receptors

2. Viral cell recognition and entry

3. Adhesion Molecules in the Lung: An Overview

4. The major human rhinovirus receptor is ICAM-1

5. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral Potential of Azelastine against Major Respiratory Viruses;Viruses;2023-11-23

2. Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients;Scientific Reports;2023-04-26

3. COVID-19: Azelastine nasal spray Reduces Virus-load In Nasal swabs (CARVIN) Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients – results from a randomized, double-blind, placebo-controlled phase II clinical trial.;2022-08-09

4. The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue;Frontiers in Pharmacology;2022-06-30

5. The Anti-histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits SARS-CoV-2 Infection in Reconstituted Human Nasal Tissue In Vitro;2020-09-15